Ramucirumab-related osteonecrosis of the jaw

Oral Oncol. 2022 Feb:125:105660. doi: 10.1016/j.oraloncology.2021.105660. Epub 2021 Dec 24.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Humans
  • Osteonecrosis* / chemically induced
  • Ramucirumab

Substances

  • Antibodies, Monoclonal, Humanized